1. Home
  2. Nation
  3. Now India will get dengue vaccine, ICMR is going to start phase-3 trial

Now India will get dengue vaccine, ICMR is going to start phase-3 trial

By Renu Mishra 
Updated Date

Dengue Vaccine in India: Dengue vaccine, which is responsible for hundreds of deaths every year in India, has been awaited for a long time. From corona to HPV vaccine for cervical cancer, everything has been made in India, so a good news has come about when the dengue vaccine will come.

Also Read :- Kangana Ranaut looked like a royal queen at PM Modi's swearing-in ceremony

According to the information given by the Indian Council of Medical Research, India is likely to get a country-made dengue vaccine soon. Let us tell you that the dengue vaccine has been made in India and its two phase trials have also been done.

After the success in both of these, the phase three trial of this vaccine is to be done, which will be done by ICMR. In its first trial, the safety of the vaccine was checked. In the second trial, it was seen whether antibodies are formed from it or not. Now in the third trial, it will be checked how effective or not it is against dengue.

Information has been given by ICMR scientist Dr. Sarita Nair on when the Phase 3 trial of the dengue vaccine will be completed and when this vaccine will be available to the people of India to prevent dengue. Let’s know..

Answer- Phase-3 trial of dengue vaccine is going to start in the third quarter of this year. That is, two quarters of the year 2024 are going to be completed by June, so this trial is likely to start from July-August 2024.

Also Read :- Brown bear seen for the first time in India, IFS officer shared its picture

ICMR informed that 19 places have been identified in the country for this trial. It will take 3 years from enrollment to completion for this trial. ICMR is going to do this trial with full force. It is expected to be successful.

Further reading:
For the latest news and reviews, follow us on Facebook, YouTube and Twitter पर फॉलो करे...
Digital Reporter Advertisement
Digital Reporter Advertisement